Fidelity Investments
CERE

Fidelity Investments’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Fidelity Investments’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,880
Closed -$200K – 5810
2024
Q2 		$200K Sell
4,880
-1,787,470
-100% -$74.4M ﹤0.01% 3027
2024
Q1 		$75.8M Sell
1,792,350
-7,899,501
-82% -$332M 0.01% 1166
2023
Q4 		$411M Sell
9,691,851
-13,931,293
-59% -$400M 0.03% 473
2023
Q3 		$516M Buy
23,623,144
+129,355
+0.6% +$3.24M 0.04% 377
2023
Q2 		$747M Buy
23,493,789
+26,531
+0.1% +$814K 0.06% 285
2023
Q1 		$572M Buy
23,467,258
+50,126
+0.2% +$1.47M 0.05% 365
2022
Q4 		$739M Buy
23,417,132
+101,567
+0.4% +$2.87M 0.07% 267
2022
Q3 		$659M Buy
23,315,565
+1,072,181
+5% +$31.9M 0.07% 274
2022
Q2 		$588M Buy
22,243,384
+39,383
+0.2% +$1.12M 0.06% 320
2022
Q1 		$777M Buy
22,204,001
+2,694,188
+14% +$78.7M 0.06% 302
2021
Q4 		$633M Buy
19,509,813
+703,184
+4% +$24.8M 0.05% 372
2021
Q3 		$555M Buy
18,806,629
+9,969,568
+113% +$280M 0.04% 401
2021
Q2 		$226M Buy
8,837,061
+3,724,661
+73% +$53.3M 0.02% 768
2021
Q1 		$70.2M Buy
5,112,400
+798,700
+19% +$11.7M 0.01% 1229
2020
Q4 		$71.5M Buy
+4,313,700
New +$56M 0.01% 1175

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Fidelity Investments's CERE Position: Q3 2024 in Review

Fidelity Investments sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 4,880 shares — an estimated $200K sold.

Fidelity Investments first reported a position in CERE in Q4 2020 and held it in 15 quarters. The position peaked at $777M in Q1 2022. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Fidelity Investments reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Fidelity Investments sold 4,880 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $200K.
  • Fidelity Investments first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 15 quarters.
  • Fidelity Investments's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $777M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Fidelity Investments's 13F filing for Q3 2024, filed 13 Nov 2024.